SEC Form 4 · accession 0001209191-16-145800
Protagonist Therapeutics, Inc · PTGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Y Liu
Officer — Chief Scientific Officer
Period of report
Oct 11, 2016
Accepted (ET)
Oct 13, 2016 · 4:25 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001377121
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $21.58 | Oct 11, 2016 | A | 65,000 | A | — | Oct 11, 2026 | Common Stock | 65,000 | 65,000 | D |
Explanation of responses
- F1The shares subject to the option shall vest in 48 equal monthly installments from the vesting commencement date of August 10, 2016.